Tag: NTI drugs
Narrow Therapeutic Index Drugs: Why Bioequivalence Rules Are Tighter for These Medications
Narrow therapeutic index drugs require stricter bioequivalence standards to ensure patient safety. Learn how the FDA, EMA, and Health Canada regulate generics like warfarin, levothyroxine, and digoxin to prevent dangerous dosing errors.
READ MORENarrow Therapeutic Index Drugs: What Patients Need to Know
- DARREN LLOYD
- 11
Narrow therapeutic index drugs require precise dosing and regular monitoring. Learn which common medications fall into this high-risk category, why switching generics can be dangerous, and how to stay safe with simple, practical steps.
READ MORE